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We have reported previously that herpes simplex virus type 1 (HSV-1) infection disrupts normal progression
of the mammalian cell cycle, causing cells to enter a G1-like state. Infected cells were characterized by a decline
in cyclin-dependent kinase 2 (CDK2) activities, loss of hyperphosphorylated retinoblastoma protein (pRb),
accumulation of E2F-pocket protein complexes, and failure to initiate cellular DNA replication. In the present
study, we investigated the role of the pocket proteins pRb, p107, and p130 in HSV-1-dependent cell cycle
inhibition and cyclin kinase regulation by infecting murine 3T3 cells derived from wild-type (WT) mouse
embryos or embryos with deletions of pRb (pRb2/2), p107 (p1072/2), p130 (p1302/2), or both p130 and p107
(p1302/2/p1072/2). With respect to CDK2 inhibition, viral protein accumulation, viral DNA replication, and
progeny virus yield, WT, pRb2/2, and p1072/2 cells were essentially identical. In contrast, after infection of
p1302/2 cells, we observed no inhibition of CDK2 activity, a 5- to 6-h delay in accumulation of viral proteins,
an impaired ability to form viral DNA replication compartments, and reduced viral DNA synthesis. As a result,
progeny virus yield was reduced 2 logs compared to that in WT cells. Notably, p1302/2/p1072/2 double-
knockout cells had a virus replication phenotype intermediate between those of the p1072/2 and p1302/2 cells.
We conclude from these studies that p130 is a key factor in regulating aspects of cell cycle progression, as well
as the timely expression of viral genes and replication of viral DNA.
Precise temporal regulation of E2F transcription factor ac-
tivities is critical to cell growth control, as E2Fs promote ex-
pression of genes necessary for DNA replication and cell cycle
progression. A family of pocket proteins, including retinoblas-
toma protein (pRb), p107, and p130, function as the primary
regulators of E2F activities, binding to and repressing the ac-
tivity of E2Fs at specific points in the cell cycle. This repression
regulates the cascade of E2F-dependent gene transcription,
thus controlling progression through G1 and S phases. The
growth-inhibitory activities of the pocket proteins are likewise
regulated by a family of cyclin-dependent kinases (CDKs) that
phosphorylate and inactivate pRb, p107, and p130 in a cell
cycle-dependent manner. Targeted disruption in both pRb al-
leles caused embryonic lethality in mice of mixed background
(9, 29, 37, 52). Mice deficient in either p107 or p130 showed no
apparent abnormalities (11, 38), while mice deficient in both
p107 and p130 displayed neonatal lethality (11). However,
generation of p130-null mice in a pure BALB/cJ background
resulted in embryonic lethality (36). Recent studies have
shown that targeted disruption of the genes encoding all three
pocket proteins resulted in the complete loss of G1 checkpoint
control, leading to cell immortalization (14, 63).
Quiescent cells are characterized by the presence of p130-
E2F4 complexes (47, 50, 70). As cells reenter the cell cycle,
p130 is phosphorylated by G1-specific cyclin kinases and sub-
sequently targeted for ubiquitin-dependent proteolysis, though
some p130 persists in cycling cells (6, 8, 47, 70). p107-E2F4 and
pRb-E2F4 complexes appear in G1 cells (50), but pRb com-
plexes are disrupted in late G1 as a result of sequential phos-
phorylation by cyclin D-CDK4,6 and cyclin E-CDK2 com-
plexes (22, 26, 34, 42). S-phase cells are characterized by
pRb-E2F1 complexes, as well as by p107-E2F4 complexes
containing the cyclin A-CDK2 complex (50). Analysis of pro-
teins bound at promoters of S-phase genes has shown that
p107-E2F4 and p130-E2F4 complexes are abundant in prolif-
erating cells (75).
Pocket proteins mediate transcriptional repression via E2F
by a variety of mechanisms that are not yet fully understood. In
addition to binding E2F and blocking the ability of free E2F to
activate transcription, the pocket proteins can complex with
E2F to form active transcriptional repressor complexes that
occupy E2F binding sites on DNA (reviewed in references 17,
25, and 53). Pocket protein-E2F complexes function as active
repressors of transcription by recruiting chromatin remodeling
enzymes such as histone deacetylase (2, 43, 44) or the SWI/
SNF complex (reviewed in reference 25), as well as other
transcriptional repressors, including HBP1 (73) and the core-
pressors CtIP and CtBP (49).
In addition to their role as regulators of E2F, p107 and p130
(but not pRb) have been identified as inhibitors of CDKs (7,
16, 35, 77). The pocket region of p107 and p130, which is larger
than that of pRb, contains a motif that mediates CDK binding.
The binding of p107 or p130 to cyclin A-CDK2 or cyclin E-
CDK2 negates the activities of these kinases, and p130-cyclin
A-CDK2 complexes with or without E2F have been identified
in vivo (76). Indeed, the level of inhibition of cyclin E-CDK2
and cyclin A-CDK2 by p107 has been demonstrated to be
comparable to that of the CDK inhibitor p21 (7). Thus, p107
and p130 have dual roles in the control of cell cycle entry and
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progression as regulators of both the E2F family of transcrip-
tion factors and the CDKs.
We and others have previously reported that herpes simplex
virus type 1 (HSV-1) infection results in the accumulation of
cells in a G1-like state, characterized by loss of hyperphospho-
rylated pRb, decline in G1 CDK activities, and failure to ini-
tiate cellular DNA replication (18, 27, 54, 71). Coincident with
the onset of viral DNA replication there is an increase in the
E2F-p107-cyclin A-CDK2 complexes, hyperphosphorylation
and nuclear translocation of E2F4, and posttranslational mod-
ification and cytoplasmic translocation of E2F1 and a decrease
in E2F DNA binding activities and E2F-dependent trans-acti-
vation (1, 27, 54). Quiescent human fibroblasts infected with
HSV-1 are unable to exit G0 in response to mitogen, as char-
acterized by persistence of E2F-p130 complexes and failure to
upregulate G1 CDK activities (18). Common to HSV-1 infec-
tion of both quiescent and asynchronously cycling cells is the
disregulation of CDK2 activities.
Based on the knowledge that p107 and p130 function as
inhibitors of both E2F and CDK2, we investigated their role in
HSV-1-induced cell cycle aberrations. Specifically, we wanted
to establish whether one or both of these pocket proteins are
necessary for HSV-1-dependent inhibition of CDK2 activities.
To address these questions, we investigated the effects of
HSV-1 on cell lines derived from mice deficient for pRb, p107,
p130, or both p107 and p130 (10). The growth properties of
these 3T3 fibroblast cell lines have been described previously
(10). Briefly, the pRb2/2 and p1302/2/p1072/2 cell lines dis-
play a shortened G1 and lengthened S phase compared to
wild-type (WT) cells, and each cell line shows differential reg-
ulation of E2F-dependent gene promoters and CDK activities.
We report here that after infection of WT, pRb2/2, and
p1072/2 cells by HSV-1, CDK2 activity was reduced 60 to 80%
compared to that in mock-infected cells, while p1302/2 cells
showed no decline in CDK2 activity. Additionally, pRb2/2 and
p1072/2 cells supported HSV-1 replication at levels compara-
ble to that of WT cells, while p1302/2 cells were impaired in
their ability to support viral replication. HSV-1 infection of
p1302/2 cells was characterized by a 5-h delay in immediate-
early (IE) and delayed-early (DE) viral protein production, a
delay in viral DNA replication, a lag and reduction in late (L)
viral protein accumulation, and a 2-log reduction in virus yield.
Cells deficient for both p130 and p107 (p1302/2/p1072/2) had
an intermediate phenotype. These findings establish a critical
role for p130 in HSV-1 replication, which may point to its
involvement in HSV-1-dependent cell cycle regulation.
MATERIALS AND METHODS
Cells and viruses. Vero cells, originally obtained from D. Knipe, Harvard
University, were maintained in Dulbecco’s modified Eagle medium with high
glucose (DMEM-H), supplemented with 5% bovine calf serum (CS); 129/BL6
3T3 cell lines derived from WT mouse embryos or mouse embryos with deletions
of pRb (pRb2/2), p107 (p1072/2), p130 (p1302/2), or both p130 and p107
(p1302/2/p1072/2) (10) were obtained from M. Classon and E. Harlow, MGH
Cancer Center, and were maintained in DMEM-H supplemented with 10% CS.
HSV-1 strain KOS1.1 was used for all experiments unless otherwise indicated.
HSV d107 and HSV d99 viruses were a kind gift from N. DeLuca, University of
Pittsburgh (64). A green fluorescent protein (GFP)-expressing Sindbis virus
derived from TR339 consensus AR339 strain (32) was a kind gift of W. Klimstra,
University of North Carolina—Chapel Hill.
Detection of proteins. Cellular and viral proteins were detected by Western
blot analysis essentially as described previously (18). The following antibodies
were used: anti-CDK2 (M2, sc-163), anti-CDK2 (D12, sc-6248), anti-p107 (C18,
sc-318), anti-p130 (C20, sc-317), and anti-mouse immunoglobulin G (IgG)–
horseradish peroxidase (sc-2005), all from Santa Cruz Biotechnology; anti-pRb
(14001A) from Pharmingen; anti-rabbit Ig–horseradish peroxidase (NA 934),
from Amersham; anti-ICP27 (H1113), from the Goodwin Institute; anti-ICP0
(H1083) and anti-ICP4 (H943), a gift from Lenore Pereira, University of Cali-
fornia at San Francisco; anti-ICP8 (3–83), a gift from David Knipe, Harvard
University; anti-gC (R47), a gift from Roselyn Eisenberg and Gary Cohen,
University of Pennsylvania; and anti-Us11 (28*), a gift from Bernard Roizman,
University of Chicago.
Immunofluorescence. 3T3 cells (ca. 5 3 104) were seeded in wells of 24-well
tissue culture dishes each containing a 12-mm glass cover circle. After 1 day, cells
were infected at a multiplicity of infection (MOI) of 20 with HSV for 1 h at 37°C.
Following removal of the inoculum, cells were overlaid with DMEM-H with 2%
CS. At various times postinfection (p.i.), cells were fixed at room temperature for
8 min in paraformaldehyde (Fisher) diluted to 1% in phosphate-buffered saline
(PBS). Circles were then rinsed in PBS for 5 min and permeabilized for 8 min in
Triton X-100 (Sigma) diluted to 0.02% in PBS. Following rehydration in PBS,
cells were incubated in blocking solution containing 2.5% normal goat serum and
2.5% normal horse serum in PBS for 15 min at room temperature. Cells were
then incubated for 60 min at 37°C with a 1:800 dilution of rabbit anti-ICP8
antiserum (3–83) in blocking solution. After three 5-min rinses in PBS and one
5-min incubation in blocking solution, cells were next incubated with a 1:50
dilution of a Texas red-coupled goat anti-rabbit IgG for 60 min at 37°C. Follow-
ing three 5-min rinses in PBS, the glass circles were rinsed in distilled H2O and
mounted on microscope slides in polyvinyl alcohol and glycerol containing 0.25%
diazabicyclo[2.2.2]octane, 2% n-propyl gallate, and 0.1% DAPI (49,69-diamidino-
2-phenylindole) and stored at 4°C. Microscopy was performed on a Zeiss micro-
scope fitted with a multipass filter for Texas red. Images were captured digitally
using the Scion Image program, saved in TIF format, and transferred to Adobe
Photoshop.
Immunocomplex kinase assay. CDK2 protein complexes were immunopre-
cipitated from protein equivalent amounts (200 to 300 mg) of whole-cell lysate
with anti-CDK2 rabbit polyclonal antibody (Santa Cruz; M2; sc-163) for 12 h at
4°C. Protein complexes were collected on protein A-agarose beads (Boehringer
Mannheim) for 1 h at 4°C and washed twice with 0.2% Tween 20 lysis buffer (50
mM HEPES [pH 7.3], 150 mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 0.2% Tween
20) and twice with kinase buffer (50 mM HEPES [pH 7.3], 10 mM MgCl2). An
immunocomplex kinase assay was performed using histone H1 as the substrate
exactly as described previously (18).
GFP expression. Subconfluent monolayers of WT and p1302/2 cells in 60-mm
dishes were infected with HSV d107 at 10 or 20 PFU/cell, or Sindbis-GFP at 10
PFU/cell. At 5, 24, and 36 h p.i., cells were examined by UV microscopy (Nikon
TE300) to visually confirm GFP expression and then harvested by trypsinization.
Cells were pelleted and then resuspended in 250 ml of 13 PBS and fixed by the
addition of 250 ml of 13 PBS–2% paraformaldehyde. The proportion of GFP-
positive cells was determined by flow cytometry analysis using a FACScan in-
strument (Becton-Dickinson). Fifteen thousand cells were sorted for each sam-
ple type, and GFP-positive cells were determined to be those with FL1
fluorescence above the level detected in mock-infected control cells of the ap-
propriate genotype.
Southern blot analyses of viral DNA. Subconfluent cultures of WT, p1072/2,
p1302/2, and p1302/2/p1072/2 cells in 100-mm dishes were infected with 20
PFU of HSV-1/cell. At various times p.i., cells were harvested by trypsinization
and resuspended in 5 ml of 13 PBS. Cells were pelleted through 1 ml of CS and
then resuspended in 200 ml of 13 PBS with 0.2 mg of RNase A and 0.4 mg of
protease K. Cellular and viral DNA were extracted using the QIAamp DNA
minikit (Qiagen) according to the manufacturer’s protocol for adherent cells.
DNA was eluted in 200 ml (final volume) of buffer AE (10 mM Tris-HCl–0.5 mM
EDTA; pH 9.0), giving a final concentration of ;0.1 mg/ml. For each sample, 10
mg of DNA was diluted to 400 ml in 0.4 M NaOH–10 mM EDTA and boiled for
10 min. DNA was vacuum slot blotted onto a positively charged nylon membrane
(Boehringer Mannheim), and each well was then rinsed with 500 ml of 0.4 M
NaOH. Following disassembly of the slot blot apparatus, the membrane was
rinsed in 23 SSC, dried, and UV cross-linked. The membrane was prehybridized
for 1 h at 42°C in DIG Easy Hyb buffer (Roche) and then hybridized for 16 h at
42°C with a digoxigenin-labeled DNA probe, specific for the HSV-1 terminal and
internal inverted repeats (BamHI-SP2) (58), at a concentration of 25 ng/ml.
Following hybridization, the membrane was washed and the digoxigenin probe
was detected exactly according to the DIG High Prime DNA labeling and
detection starter kit II protocol (Roche). Following detection, the membrane was
exposed in a Lumi-Imager (Boehringer Mannheim) for 10 min, and band inten-
sity was determined as the number of Boehringer luminescent units (BLU) per
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slot. Membranes were also exposed to BioMax-MR film (Kodak) for 5 min to 1 h
to obtain an image on film.
Cell synchronization. WT and p1302/2 cells were synchronized by contact
inhibition. Cells were grown to confluence by maintaining them in DMEM-H
with 10% CS for 4 days after plating in 100-mm dishes and then released into cell
cycle by replating at a lower density (8 3 105 cells/dish) in fresh DMEM-H with
10% CS on 100-mm dishes. Synchronization was verified by flow cytometry
analysis for DNA content of propidium iodide-stained cells exactly as described
previously (18).
Virus yield assay. Replicate 60-mm monolayers of WT, pRb2/2, p1072/2,
p1302/2, and p1302/2/p1072/2 cells were infected with 5 PFU of HSV-1/cell,
and cells and medium were harvested at various times p.i. Following three cycles
of freezing and thawing, monolayers of Vero cells in 12-well dishes were inoc-
ulated in triplicate with serial 10-fold dilutions of the lysates. After 1 h, mono-
layers were covered with DMEM-H containing 2% CS and 0.3% methylcellulose.
Following 3 days of incubation at 37°C, medium was aspirated from the wells and
plaques were stained with 0.8% crystal violet in 50% ethanol. Plaques were
counted, and virus yield was determined as the number of PFU generated per
cell.
Generation of figures. Figures 1 to 4 and 6 to 7 were created using Microsoft
PowerPoint. Images of original autoradiograms were generated using a desktop
scanner, saved as bit-map files, and then imported into Microsoft PowerPoint.
Figure 5 was created using Adobe Photoshop.
RESULTS
CDK2 inhibition by HSV-1 is independent of pRb and p107
but requires p130. To explore the potential role of pocket
proteins in the HSV-1-dependent down regulation of CDK2
activities, 3T3 fibroblasts derived from WT, pRb2/2, p1072/2,
p1302/2, and p1302/2/p1072/2 mouse embryos were mock
infected or infected with 50 PFU of HSV-1 per cell, harvested
at 8 h p.i., and analyzed for CDK2 activity. A high MOI was
used because we had previously determined that MOI 5 infec-
tions of NIH 3T3 and 129/BL6 3T3 cells resulted in up to a
10-fold decrease in virus yield per cell compared to infections
of Vero cells at the same MOI (T. I. McLean and S. L. Bachen-
heimer, unpublished data), and we wanted to ensure maximally
synchronous infection and efficient expression of IE and DE
proteins. CDK2 complexes were immunoprecipitated from
protein equivalent amounts of whole-cell lysates and the kinase
activity of these complexes was determined in an in vitro kinase
assay. As had previously been shown in various human cell
lines (18, 71), HSV-1 infection of WT 3T3 cells resulted in an
up to 60% reduction of CDK2 activity compared to mock-
infection when activity was normalized to CDK2 protein levels
(Fig. 1, lanes 1 and 2). p1072/2 and pRb2/2 cell lines also
displayed a 60 to 80% decrease in CDK2 activity following
HSV-1 infection (Fig. 1, lanes 3, 4, 9, and 10). Assays of
p1302/2/p1072/2 lysates demonstrated a 30% decline in
CDK2 activity (Fig. 1, lanes 7 and 8). In contrast, infected
p1302/2 cells displayed no loss in CDK2 activity compared to
mock-infected samples (Fig. 1, lanes 5 and 6). These results
suggested that HSV-1 inhibits cyclin kinase activities indepen-
dently of pRb and p107. The failure to detect any effect of
HSV-1 on CDK2 activity in the p1302/2 cells suggests that
p130 is essential for HSV-1-dependent regulation of cyclin
kinase activity. Alternatively, p130 may be important for virus-
mediated effects on the infected cell upstream of CDK2 inhi-
bition. While conducting these assays, we observed that in
addition to not supporting a decrease in CDK2 activity,
p1302/2 cells did not display a cytopathic effect even 10 h after
HSV-1 infection (data not shown). This observation prompted
us to examine several additional aspects of the HSV-1 repli-
cation cycle in the p1302/2 cell line.
HSV-1 replication is severely impaired in p1302/2 cells.
Due to the inability of HSV-1 to inhibit CDK2 activity or to
induce cytopathic effect in cells lacking p130, we hypothesized
that these cells would be impaired in their ability to support
HSV-1 replication. We performed a one-step growth curve,
comparing HSV-1 replication in p1302/2 cells to that in WT
cells and other knockout cell lines. WT, pRb2/2, p1072/2,
p1302/2, and p1302/2/p1072/2 cells were infected with 5 PFU
per cell and harvested at 8, 12, 16, or 24 h p.i. The amount of
progeny virus produced by each culture was determined by
standard plaque assay and expressed as the number of PFU per
105 cells (Fig. 2). Although all of these mouse cell lines were
inefficient at supporting virus replication compared to human
or other primate cell lines, it was readily apparent that the
p1302/2 cells were impaired to a greater extent than WT cells.
The virus yield from p1302/2 cells was reduced 2 logs com-
pared to that from WT cells at 16 h p.i. The difference in yield
narrowed to 1 log at 24 h p.i., as virus production in WT cells
leveled off and production in p1302/2 cells continued to in-
crease. Virus production in p1302/2 cells, however, never
reached levels comparable to that in WT cells, even at 40 h p.i.
(data not shown). Yield experiments performed at MOIs of 50
and 20 revealed that the 16-h HSV-1 yields were 1 and 2.5 logs
lower, respectively, in p1302/2 cells than in WT cells. This
confirmed that the HSV-1 replication impairment in p1302/2
cells was not MOI dependent (data not shown; see Fig. 7B).
Cells lacking pRb or p107 showed less significant differences
in yield compared to WT cells. Virus yield produced by
pRb2/2 cells closely mirrored that produced by WT cells, while
virus yield produced by p1072/2 cells exceeded that of WT
cells at 12, 16, and 24 h p.i. Interestingly, cells lacking both
FIG. 1. Regulation of CDK2 activity in HSV-1 infected 3T3 cell
lines. WT and mutant 3T3 cell lines were mock infected (M) or in-
fected with HSV-1 at 50 PFU/cell (I) and harvested after 8 h of
infection. CDK2 was immunoprecipitated (IP) from protein equivalent
amounts of whole-cell lysate. One half of the immunoprecipitate was
used to determine the relative kinase activity of CDK2 using histone
H1 substrate by in vitro kinase assay. The other half of the immuno-
precipitate was used to detect CDK2 protein by Western blotting
(WB). The bar graph represents the kinase activity of each infected
sample relative to that of the corresponding mock-infected sample,
normalized to the amount of CDK2 protein in the immunoprecipitate.
Kinase activity was quantified by phosphorimaging. Protein levels were
quantified by laser densitometry.
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p130 and p107 were not as impaired in supporting virus repli-
cation as the p130 single-knockout cells, with HSV-1 yield
being approximately 1 log lower than that of the WT at 16 h p.i.
This result was consistent through three separate experiments
(see Discussion).
WT and p1302/2 cells are equally susceptible to HSV-1
infection. Due to the severe impairment in virus replication
and the failure to detect loss of CDK2 activity following HSV-1
infection in p1302/2 cells, we were interested in whether the
absence of p130 affects the ability of the virus to efficiently bind
and enter cells or whether p130 is important for a function
downstream of entry. We used GFP expression as a marker for
HSV-1 susceptibility by infecting cells with d107, a virus engi-
neered to express GFP under the control of the human cyto-
megalovirus (HCMV) IE promoter (64). We hypothesized that
if HSV-1 is equally able to bind and enter both WT and
p1302/2 cells, GFP expression should be observed in an equiv-
alent number of cells of both genotypes. To that end, subcon-
fluent populations of WT and p1302/2 cells were infected with
d107 at an MOI of 10 or 20. At 5, 24, and 36 h after infection,
cells were harvested by trypsinization and fixed, and the per-
cent GFP-positive cells was determined by flow cytometry
analysis. At 5 h p.i. the fraction of GFP-positive p1302/2 cells
was smaller than the fraction of GFP-positive WT cells at both
MOIs tested (Fig. 3A). However, at 24 and 36 h p.i., WT cell
populations were 100% GFP-positive and p1302/2 cell popu-
lations were 80% GFP positive when infected at an MOI of 10,
and both WT and p1302/2 cell populations were nearly 100%
GFP positive when infected at an MOI of 20. These data
indicate that although p1302/2 cells are initially delayed in
expression of the GFP trans gene, the two cell types are equally
susceptible to HSV-1 infection.
The delay in GFP expression in p1302/2 cells at 5 h was
unexpected, as this expression was under the control of a
strongly constitutive HCMV IE promoter. Because the DNA
genome of HSV-1 requires transport into the nucleus before
viral gene expression can occur, we determined whether a
cytoplasmically replicating virus would show a similar impair-
ment in GFP expression in p1302/2 cells. Infection of p1302/2
cells with GFP-expressing Sindbis virus, a cytoplasmically rep-
licating RNA virus, resulted in efficient GFP expression ex-
ceeding that seen in WT cells (Fig. 3B). Thus, expression of
GFP in the cytoplasm was not delayed in p1302/2 cells com-
pared to WT cells. These data suggest that p1302/2 cells may
impose a block to efficient nuclear DNA virus-mediated gene
expression or at the very least to expression from the HCMV
IE promoter.
Accumulation of viral proteins is delayed and reduced in
p1302/2 cells. The failure to detect significant progeny virus
production in cells lacking p130, despite the fact that every cell
was capable of receiving at least one infectious particle, sug-
gested that the absence of p130 impaired the virus replication
cycle at a point after entry and localization of viral DNA in the
nucleus. To assess the replication cycle at the level of viral gene
expression we analyzed the kinetics of infected-cell protein
production by Western blot analyses. We examined proteins
from the IE, DE, and L gene classes. Subconfluent monolayers
of WT, p1302/2, and p1302/2/p1072/2 cells were infected with
FIG. 2. One-step growth curve of HSV-1 on 3T3 cell lines. Sub-
confluent monolayers of WT and mutant cell lines were infected with
5 PFU of HSV-1/cell. The virus titer of each culture harvested at 8, 12,
16, and 24 h p.i. was determined by standard plaque assay as described
in Materials and Methods. The virus yield displayed is representative
of three separate experiments and is expressed on a semilogarithmic
scale.
FIG. 3. Susceptibility of WT and p1302/2 cells to HSV-1 infection.
Subconfluent monolayers were infected with GFP-expressing viruses:
HSV d107 at 10 or 20 PFU/cell (A) or Sindbis-GFP at 10 PFU/cell (B).
Cells were harvested by trypsinization at 5, 24, or 36 h p.i. and fixed in
1% paraformaldehyde. The percent GFP-positive cells was determined
by flow cytometry.
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HSV-1 at an MOI of 5 and harvested at various intervals af-
ter infection from 2 to 16 h (IE and DE proteins) or from 0 to
30 h (L proteins). Whole-cell lysates were prepared, separated
by sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis, transferred to polyvinylidene difluoride membranes,
and then probed with antibodies to viral proteins.
The Western blots (Fig. 4) revealed that the kinetics of viral
protein accumulation were similar between WT and p1302/2/
p1072/2 cells for all three classes of viral proteins, although
the level of protein accumulation was slightly reduced in the
p1302/2/p1072/2 cells. IE proteins ICP0, ICP4, and ICP27
were first detected between 2 and 3 h p.i., DE protein ICP8 was
first detected at 3 h p.i., and L proteins gC and Us11 were first
detected at 8 h p.i. gC accumulation was undetectable between
2 and 8 h p.i. (data not shown). In contrast, p1302/2 cells
showed a delay in viral protein accumulation ranging from 4 to
6 h. Specifically, ICP4, ICP27, and ICP8 were first detected no
earlier than 4 to 5 h after these proteins first appeared in WT
cells (Fig. 4A and B), and ICP0 was barely detectable in
p1302/2 cells even at 16 h p.i. (Fig. 4A). Interestingly, by 12 h
p.i., levels of ICP27 and ICP8 were comparable to levels de-
tected in WT cells by 5 to 6 h p.i. Infections performed at 20
PFU per cell provided the same pattern of protein accumula-
tion kinetics for all IE and DE proteins shown (data not
shown).
In experiments using 5 PFU per cell, it appeared that L
protein gC was not detectable in p1302/2 cells, so we per-
formed the experiments presented in Fig. 4C at 50 PFU per
cell. Even at the higher MOI, gC was below the level of de-
tection in the experiment shown. However, in other experi-
ments and with longer exposures, we were able to detect gC at
very low levels. In these experiments, L proteins gC and Us11
accumulated in p1302/2 cells to levels that were less than 10%
of those found in WT cells, and their accumulation was delayed
about 8 h compared to that in WT cells (Fig. 4C). p1302/2
cells, therefore, can support a program of HSV-1 viral gene
expression that lags behind that of a productive infection in
WT cells. One exception is the inability to detect significant
levels of ICP0, which may itself contribute to the delay in
accumulation of other IE, DE, and L gene products in the
absence of p130. The virus yield obtained with an ICP0-null
virus (d99) on WT cells at 24 h p.i. was almost identical to that
of WT KOS virus on the p1302/2 cells (both reduced 2.5 logs
compared to WT KOS on WT cells; data not shown). Addi-
tionally, the d99 virus yield was reduced only 0.5 log compared
to the WT KOS virus on the p1302/2 cells at 24 h p.i. (data
not shown). These data support the idea that the failure of
p1302/2 cells to support expression of significant levels of ICP0
protein may contribute to the overall replication deficiencies
seen in this cell line.
p1302/2 cells are impaired in the formation of viral DNA
replication compartments and support reduced levels of viral
DNA replication. Since expression of true L genes depends
upon the onset of viral DNA replication (62), we hypothesized
that the low levels of gC and Us11 seen in p1302/2 cells were
due to an inhibition of viral DNA replication in these cells. We
used two separate methods to compare viral DNA synthesis in
WT and p1302/2 cells. First, we looked for the formation of
viral DNA replication compartments as visualized by immuno-
fluorescence microscopy for ICP8. This virus-encoded DNA
binding protein is absolutely required for complete prerepli-
cative complex formation and DNA synthesis (3, 12, 15, 23, 39,
40, 55, 59). Prior to the onset of viral DNA synthesis, ICP8
accumulates at either a small number of ND10s or a larger
number of sites corresponding to sites of cellular DNA syn-
thesis (41, 74). The former are also sites where parental ge-
nomes have been detected (28, 46). At early times and prior to
the onset of viral DNA replication the ICP8 staining pattern
FIG. 4. Kinetics of viral protein accumulation in 3T3 cell lines. WT, p1302/2/p1072/2, and p1302/2 cells were infected with HSV-1 at 5 PFU/cell
(A and B) or 50 PFU/cell (C) and harvested at various times after infection. Cells were scraped into SDS sample buffer, and cell-equivalent
amounts of lysate were separated by SDS-polyacrylamide gel electrophoresis. The resolved proteins were transferred to a polyvinylidene difluoride
membrane, and viral proteins were visualized by Western blotting with antibodies directed to IE proteins ICP0, ICP4, and ICP27, DE protein ICP8,
or true L proteins gC and Us11.
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takes on a punctate appearance. As viral DNA synthesis pro-
ceeds, the staining pattern evolves to a globular appearance as
replication compartments begin to fill the nucleus (15, 48, 59).
In WT cells infected with 20 PFU of HSV-1 per cell, a punctate
or globular nuclear ICP8 staining pattern was observed in
almost 100% of cells at 5 h p.i. (Fig. 5A and B). By 16 h p.i. the
ICP8 staining pattern had transitioned to globular structures in
most cells, indicating progression of viral DNA replication
(Fig. 5D). In the presence of 400 mg of the viral DNA poly-
merase inhibitor phosphonoacetic acid (PAA; Sigma) per ml,
only punctate or diffuse nuclear ICP8 staining was observed
(Fig. 5C). This concentration of PAA was sufficient to reduce
viral DNA synthesis to undetectable levels in these cell lines
(data not shown). As expected from the Western blot data for
ICP8 protein (Fig. 4B), less than 1% of p1302/2 cells displayed
ICP8 staining at 5 h p.i. (Fig. 5E and F), and this staining was
punctate or globular and reminiscent of that seen in WT cells
at 5 h. At 16 h p.i., however, approximately 10 to 20% of
p1302/2 cells displayed punctate or globular ICP8 staining
(Fig. 5G and H). In a separate experiment we saw that the
proportion of ICP8-positive p1302/2 cells increased an addi-
tional 17% between 16 and 24 h p.i. (data not shown).
The results of ICP8 immunofluorescence microscopy indi-
cated that formation of viral DNA replication compartments
was impaired in cells lacking p130, since few if any cells showed
evidence of punctate or globular ICP8 staining patterns. In
order to directly assess the level of viral DNA replication in
p1302/2 cells, we performed Southern blot analyses on DNA
extracted from HSV-1-infected cells. Subconfluent monolayers
of WT, p1072/2, p1302/2, and p1302/2/p1072/2 cells were
infected with HSV-1 at 20 PFU per cell. Cells were harvested
at 4, 8, 12, 16, and 24 h p.i., total DNA was extracted, and
samples were slot blotted to nylon membranes and hybridized
with an HSV-1-specific DNA probe (Fig. 6A). The amount of
viral DNA in each sample was quantified, and the data are
presented as the number of BLU per sample plotted as a
function of hours postinfection (Fig. 6B). The slot blot re-
vealed impaired viral DNA synthesis in p1302/2 cells com-
pared to each of the other cell types (Fig. 6A). Again, the onset
of viral DNA accumulation was delayed in p1302/2 cells com-
pared to WT cells and was 12% of the WT value at 12 h p.i.,
22% of the WT value at 16 h p.i., and 53% of the WT value at
24 h p.i. (Fig. 6B). Of interest was the observation that at 12 h
p.i., when p1302/2 cells expressed significant amounts of ICP4,
ICP27, and ICP8, DNA replication was only 12% of that of
WT cells (Fig. 4B). These data corroborate the ICP8 immu-
nofluorescence studies, indicating that viral DNA replication is
significantly impaired and delayed in cells lacking p130 even in
the presence of seemingly adequate amounts of viral IE and
DE proteins. The detection of limited viral DNA synthesis in
p1302/2 cells by 16 h p.i. is consistent with the ability to detect
minimal amounts of gC and Us11 proteins at this time point
(Fig. 4C). In the experiment presented, it appeared that the
levels of viral DNA peaked in WT cells at 12 h p.i. and then
declined. However, in two additional experiments we found
that the level of viral DNA plateaued in WT cells beginning at
12 h p.i. (data not shown).
Efficiency of HSV-1 replication in p1302/2 cells is cell cycle
dependent. Southern blot analyses showed that overall viral
DNA synthesis was reduced in p1302/2 cells compared to that
in WT cells. We found by immunofluorescence microscopy,
however, that some cells displayed a pattern and kinetics of
ICP8 staining similar to those of WT cells. In addition, by 16
and 24 h p.i., the fraction of p1302/2 cells with punctate or
globular ICP8 staining had increased considerably. We hypoth-
esized that at the time of infection of this asynchronous cell
population, only cells at one or more discrete stages of the cell
cycle were capable of or had the potential to support virus
replication. Furthermore, as additional cells within the popu-
lation cycled through these discrete stages, they gained the
ability to support viral gene expression. In order to test the idea
that HSV-1 replication in p1302/2 cells is cell cycle dependent,
WT and p1302/2 cells were synchronized in G0 by contact
inhibition, released by replating at lower density, and then
infected at different times after release from G0. Cells were
infected at 4-h intervals from 0 to 24 h after replating and
harvested 16 h after infection. Progeny virus production was
determined by standard plaque assay and expressed as PFU
per cell (Fig. 7C). Additionally, we harvested cells from two
duplicate plates at each time of infection to assess the cell cycle
status and level of CDK2 activity in each culture at the onset of
infection. Cell cycle profiles were determined by measuring the
DNA content of propidium iodide-stained cells by flow cytom-
etry analyses. CDK2 activity was determined by in vitro kinase
assay as described above. An average of the cell cycle profiles
of synchronized WT and p1302/2 cells from three separate
experiments (Table 1), as well as the timing of CDK2 activa-
tion (Fig. 7A and B), revealed that WT cells transitioned from
G1 to S phase between 16 and 20 h after release, while p130
2/2
cells transitioned from G1 to S phase between 8 and 12 h after
release. Analyses of virus yield revealed that progeny virus
production in WT cells did not vary with the phase of the cell
cycle that cells were in at the time of infection or with the level
of CDK2 activity (Fig. 7C). In contrast, we found that p1302/2
cells showed an inverse correlation between viral progeny pro-
duction and CDK2 activity. In p1302/2 cells, we observed the
highest levels of HSV-1 production in cultures infected 4 and
8 h postplating (early and mid-G1 phase), when CDK2 levels
were low, and the lowest levels of virus production in cultures
infected 16 to 24 h postplating (S to G2/M phase), when CDK2
levels were high (Fig. 7B and C). The increased virus yield
observed as a function of cell cycle could reflect either in-
creased efficiency of virus replication in a small number of cells
or an increased number of cells able to support virus repli-
cation. To differentiate between these possibilities, synchro-
nized WT and p1302/2 cell populations were infected at dif-
ferent times after replating and the pattern of ICP8 staining
was determined by immunofluorescence microscopy at 5 or
16 h p.i. In one experiment, when p1302/2 cells were infected
in G0 or early G1 (0 or 8 h after replating), 63 and 60% of cells
subsequently demonstrated globular ICP8 staining at 16 h p.i.
(Table 2). Only 2% of cells demonstrated globular ICP8 stain-
ing when p1302/2 cells were infected during S phase (16 h after
replating) or G2/M phase (24 h after replating). The great
majority of WT cells demonstrated globular ICP8 staining at
5 h p.i. regardless of the cell cycle phase at the time of infection
(Table 2). These data indicate that in p1302/2 cells, but not
WT cells, HSV-1 replication is cell cycle dependent. This find-
ing lends credence to the idea that the individual p1302/2 cells
displaying punctate or globular ICP8 staining at earlier times
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FIG. 5. Formation of viral DNA replication compartments in WT and p1302/2 cells. WT and p1302/2 cells were seeded onto 12-mm glass cover
circles and later infected with 20 PFU of HSV-1/cell. Cells were fixed in 1% paraformaldehyde in PBS and permeabilized in 0.2% Triton X-100
in PBS. Viral replication compartments were visualized by detection of DE protein ICP8 (red) by immunofluorescence at 5 or 16 h p.i. (5h and
16h, respectively). Cellular DNA was detected by DAPI staining (blue).
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than the rest of the culture were passing through a discrete
window in early to mid-G1 phase when infected.
DISCUSSION
In an attempt to understand the mechanism by which HSV-1
regulates CDK2 activity after infection, we have discovered
that the pocket protein p130 is critical for HSV-1 replication.
First, p1302/2 cells did not support a reduction in CDK2
activity after HSV-1 infection, as we had observed in other
pocket protein-null cells and a variety of other human and
primate cell lines. Second, infection of p1302/2 cells resulted
in a temporal lag in viral IE and DE protein synthesis, accom-
panied by a delay and decrease in viral DNA replication and L
protein synthesis. The accumulation of IE proteins ICP4 and
ICP27 was delayed 5 h in p1302/2 cells, while accumulation of
ICP0 was barely at the level of detection at any time. This
significant reduction in ICP0 production could account for the
delay in IE, DE, and L protein synthesis, because ICP0 has a
well-documented role in promoting viral gene transcription
both in vitro and in vivo (5, 65). Additionally, both the reduc-
tion in viral DNA replication (as much as 10-fold at 12 h p.i.)
and the reduction in abundance of L proteins such as gC to
levels less than 10% of that in WT cells help to explain the
2-log reduction in progeny virus formation in p1302/2 cells,
despite equal susceptibility to virus binding and entry. These
data suggest a delay in the onset of viral gene transcription
after binding and entry, as well as additional impairment in
viral DNA synthesis, leading to severe reduction in L protein
synthesis. We also observed that although IE and DE proteins
(with the exception of ICP0) eventually accumulated to almost
WT levels in p1302/2 cells, levels of viral DNA synthesis and L
protein accumulation did not reach WT levels even by 24 h p.i.
These data suggest an uncoupling between IE and DE protein
synthesis and DNA replication in p1302/2 cells. It appears,
thus, that the impairment in viral DNA replication, and not the
delay in IE and DE protein accumulation, is rate limiting for
progeny virus production in p1302/2 cells.
3T3 cells lacking pocket protein pRb or p107 supported
HSV-1 replication at levels comparable to that found in the
parental WT cells. Additionally, in the absence of either
pocket protein, CDK2 activity declined after virus infection,
suggesting that neither of these proteins plays a critical role in
HSV-1-dependent cyclin kinase regulation. p1072/2 cells, in
fact, supported HSV-1 progeny formation at levels slightly
higher than those of the WT cells, leading us to propose that
deletion of p107 may actually enhance HSV-1 replication. The
current understanding of p107 function suggests that the role
of p107 differs from those of pRb and p130 despite their
similar structures and functional capabilities. pRb, p107, and
p130 are all known to bind histone deacetylase, recruit tran-
scriptional repression activities, and inhibit E2F-responsive
gene expression (25). One notable difference, however, is that
pRb-E2F and p130-E2F complexes are present primarily in G0
and early-G1 cells, while p107-E2F complexes first appear in
late G1 following cell cycle reentry from quiescence. In cycling
cells the p107-E2F complex persists, suggesting a proliferation-
related role for p107 rather than a role as a growth suppressor
like pRb and p130 (53). Additionally, chromatin immunopre-
cipitation has revealed that cell cycle-regulated gene promot-
ers are occupied by different pocket protein-E2F complexes at
various phases of the cell cycle (72, 75). These studies reveal
that the regulation of genes by pocket proteins and E2F is
complex and each pocket protein may play a unique and nec-
essary role in cell cycle control. If, indeed, p107 is a prolifer-
ation-promoting factor, then perhaps a virus that acts to halt
cell proliferation would benefit from its absence. These ideas
may help to explain why, in the p130/p107 double-knockout
cell line, HSV-1 replication was only modestly reduced and
kinetics of viral protein accumulation were comparable to
those in WT cells. If the absence of growth suppressor p130 is
inhibitory to HSV-1 infection and the absence of proliferating
factor p107 is favorable for HSV-1 infection, then the elimi-
nation of both proteins would tend to cancel out their individ-
ual effects on HSV-1 replication. Further investigation into the
mechanisms by which p130 interacts with the HSV-1 infection
process will help us to clarify the results presented by the p130/
p107 double-knockout cell line. Additionally, though structur-
ally and functionally related, p107 and p130 have distinct cell
cycle expression patterns and roles in cellular gene expression.
FIG. 6. HSV-1 DNA replication in WT and p1302/2 cells. (A) Subconfluent 100-mm monolayers of WT and mutant cells were infected with
HSV-1 at 20 PFU/cell and harvested at the indicated times. Total cellular and viral DNA was extracted as described in Materials and Methods.
Equivalent amounts of DNA were slot blotted onto positively charged nylon membranes, and viral DNA was detected by hybridization with a DNA
probe generated from the HSV-1 BamHI-SP2 fragment. (B) Quantification of viral DNA was determined as BLU per sample and plotted as a
function of hours postinfection.
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The present study reveals an additional functional dichotomy,
since p1072/2 cells support virus replication as efficiently as
WT cells, while p1302/2 cells do not. Current efforts directed
at determining whether impaired regulation of cyclin kinase or
E2F can explain the virus replication phenotype of p1302/2
cells may shed additional light on the differing roles of p107
and p130.
The impaired infection observed in the p1302/2 3T3 cell line
may be due to secondary mutations that the cells acquired
during the process of immortalization rather than to the ab-
sence of p130. We acknowledge the importance of verifying the
direct role of p130 in efficient HSV-1 replication, and to that
end we have attempted to repair the p130 mutation by rein-
troducing p130 via transient transfection or transient expres-
sion from an adenovirus vector. To date, we have been un-
successful in detecting ectopic p130 expression and thus in
repairing the replication phenotype by either method. An al-
ternative approach will be to establish repaired p1302/2 cell
lines by stable transfection with a p130 expression vector. We
do still feel that our data are significant for the following
reason: infection of cells lacking the pocket proteins p107 and
pRb, which are closely related to p130, resulted in a normal
HSV-1 replication cycle like that observed in WT cells. The
WT, p1072/2, pRb2/2, and p1302/2 cell lines were all created
by the 3T3 method (10); however, more total passages were
required to obtain an immortalized population of p1302/2
cells. The documented secondary mutations (i.e., p53 and p16/
p19ARF status) acquired are the same in WT, pRb2/2, and
p1302/2 cells (10), yet the HSV-1 replication phenotype is
different. However, due to the high number of passages re-
quired to isolate the p1302/2 cell line, it is probable that this
cell line acquired additional secondary mutations that have yet
to be characterized. Thus, the creation of a repaired cell line
would provide the most conclusive evidence that the observed
HSV-1 replication phenotype in p1302/2 cells is due directly to
the absence of p130.
The question then remains as to the role of the pocket
protein p130 in the HSV-1 replication cycle. The two known
roles for p130 in cell growth control are the regulation of E2F
transcriptional activities and the negative regulation of CDKs.
FIG. 7. Cell cycle dependence of HSV-1 in p1302/2 cells. WT and
p1302/2cells were synchronized in G0 by contact inhibition. Cells were
released from contact inhibition by replating at a lower cell density and
infected with HSV-1 at 5 PFU/cell at 4-h intervals from 0 to 24 h after
release. The virus titer of each culture harvested at 16 h p.i. was
determined by standard plaque assay as described in Materials and
Methods. Duplicate plates were harvested at each time of infection
and used to determine the cell cycle status by flow cytometry (Table 1)
and to assess CDK2 activity by in vitro kinase assay. (A) CDK2 activity
as measured by phosphorylation of histone H1 substrate; (B) kinase
activity, expressed as phosphorimager units per reaction; (C) virus
yield, expressed as PFU per cell on a semilogarithmic scale.
TABLE 1. Cell cycle profile of WT and p1302/2 cells
synchronized by contact inhibition
Cell type Time (h)
% of cells in:
G0/G1 S G2/M
WT 0 69 23 8
8 64 29 7
16 66 29 5
20 41 53 6
24 27 53 20
p1302/2 0 82 13 5
8 88 7 5
16 21 77 2
20 11 82 7
24 50 25 25
TABLE 2. Cell cycle dependency of replication compartment
formation in WT versus p1302/2 cells
Infection time
(h)a
% of cells showing ICP8 stainingb
Expt 1 Expt 2,
p1302/2WT p1302/2
0 87.5c 63.1 66.4c
8 71.7 60.0 42.8
16 79.3 2.3 5.6
24 62.0 2.4 2.6
a Time after release from contact inhibition.
b Determined by scoring 200 to 600 cells at 5 h p.i. for WT cells and 16 h p.i.
for p1302/2 cells.
c Due to experimental variability, only 60 to 100 total cells were scored.
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Both of these functions ultimately affect the availability, local-
ization, and/or activation of transcription factor complexes di-
rectly or indirectly and thus regulate gene expression. The
HSV-1 replication program in p1302/2 cells displays both a lag
in initiation of viral protein production and a decrease in the
amount of viral protein produced, especially ICP0. Northern
blot analyses confirm that the delay in protein accumulation is
also reflected at the transcriptional level (S. DeWire and S. L.
Bachenheimer, unpublished data). It is plausible that regula-
tion of E2F-dependent transcription by p130 affects the switch
from a cellular transcription program to a viral transcription
program, perhaps by sequestering cellular transcription factors
and redirecting RNA polymerase II to viral promoters. Alter-
natively, p130-E2F complexes may help to regulate ICP0 ex-
pression specifically, thus affecting viral gene transcription as a
whole. The critical role for ICP0 in HSV-1 replication in the
p1302/2 cell line is supported by the observation that an ICP0-
null virus replicates to similar levels in WT cells as KOS virus
replicates in p1302/2 cells, and that ICP0-null virus does not
show much reduction in yield compared to KOS virus in
p1302/2 cells (data not shown).
A second possible role for p130 in HSV-1 replication is to
reduce CDK activities in order to create a cellular environment
more favorable for virus infection. We have shown previously
that HSV-1 infection results in a decline in CDK2 activity in all
human cell types tested (18). Here we show that infection
causes a decrease in CDK2 activity in WT 3T3 cells but not in
p1302/2 cells. These observations support a model in which
p130-dependent inhibition of CDK2 activity contributes to ef-
ficient HSV-1 infection, perhaps by eliminating competition
between cellular and viral DNA synthesis machinery. CDK2
activity is normally regulated in a cell cycle-dependent manner,
with low activity in early G1, increased activity at the G1/S
border, and decreased activity again in late S phase (reviewed
in references 51, 57, and 69). It is tantalizing to consider that
p130 is necessary for HSV-1 replication in a cell cycle-depen-
dent manner as well. Individual cells in the p1302/2 culture
were able to initiate HSV-1 DNA replication, as revealed by
ICP8 immunofluorescence, at earlier times than the bulk pop-
ulation. Also, infection of synchronized WT and p1302/2 cells
showed that HSV-1 yield was highest when cells were infected
during early G1 phase when CDK2 activity levels are lowest.
Immunofluorescence microscopy revealed that when infected
in early G1 phase, p130
2/2 cells displayed an increase in the
number of cells forming replication compartments, indicating
that more cells were able to pass to late stages of HSV repli-
cation. We suggest that in the absence of p130, individual cells
within the asynchronous population pass through a discrete
cell cycle window during which CDK2 activities are low and
HSV-1 is able to initiate gene transcription. In a WT cell
population, this cell cycle window would be less important
because the virus is able to down regulate CDK2 activities in a
p130-dependent manner, regardless of the cell cycle status of
the cell at the time of infection. Interestingly, it was previously
observed that an ICP0-null virus (7134) can be complemented
by a cellular factor present during early G1 phase and that this
mutant virus shows cell cycle dependency, much as the WT
KOS does in the p1302/2 cells (4). Taking into consideration
the cell cycle dependency of ICP0-null viruses and the obser-
vation that a WT KOS infection in p1302/2 cells resembles an
ICP0-null virus infection in WT cells, a functional interaction
between ICP0 and p130 becomes plausible. It is possible that in
WT cells ICP0 is able to eliminate the cell cycle dependency of
HSV-1 infection, perhaps through reduction in CDK activities
or regulation of E2F-dependent gene expression. Further in-
vestigation is necessary in order to clarify these possible mod-
els.
Previous work by Schang and colleagues indicated that
roscovitine, a drug known to inhibit several cellular CDKs,
including CDK2, CDK1 (CDC2), CDK5, and CDK7, blocks
HSV-1 replication at several levels (30, 66–68). In their studies,
roscovitine blocked HSV-1 IE and DE gene expression and
viral DNA replication independently, and they hypothesized
that one or more roscovitine-sensitive CDKs are necessary at
multiple steps in HSV-1 replication. Specifically, they pro-
posed that CDK2 may be required for HSV-1 DNA replica-
tion. However, the lack of a CDK2-specific drug does not allow
conclusive determination of the contribution of CDK2 alone to
HSV-1 replication. Our results are in direct contrast to Schang
and colleagues’ proposed role for CDK2 in HSV-1 replication.
We show in p1302/2 cells an inverse relationship between
CDK2 activity and HSV-1 replication measured as either virus
yield or viral DNA replication compartment formation. Our
results suggest that HSV-1 DNA replication proceeds most
efficiently when CDK2 activities are low, or at least during a
time in the cell cycle when CDK2 is least active. It seems
possible that the impairment in the HSV-1 replication program
in the presence of roscovitine can be attributed to an alterna-
tive target of this drug, such as CDK7, which is known to be
important for phosphorylation of the RNA polymerase II C-
terminal domain (13, 24).
Finally, we have considered a role for p130 in the localiza-
tion of parental HSV-1 genomes to sites within the nucleus
associated with ND10 (also called PML oncogenic domains).
Viral DNA replication and much of late gene transcription
occur in replication compartments that formed in proximity to
ND10 (28, 33, 41, 46, 56, 60, 61, 74). It has also recently been
shown that pocket proteins pRb, p107, and p130 localize to
perinucleolar foci in G1 and early S phase and that these sites
overlap with sites of early cellular DNA replication (31), al-
though a direct role for p130 in DNA replication has not been
shown. We consider a third model in which p130 is important
for localization of viral genomes to sites within the nucleus
where viral gene transcription will occur and in which, in the
absence of p130, viral genomes are delayed in their localization
to those sites. A different, but related, idea is that p130 is
important for the dispersal of PML from ND10. Everett and
others have shown that ICP0 is necessary for the dispersal of
PML from ND10 and that this dispersal is important for effi-
cient viral gene expression (19–21, 45). We observe that ICP0
protein accumulation is reduced in the absence of p130, and it
follows that without ICP0, PML is not dispersed and the viral
transcription program is temporally delayed. However, to
prove a role for p130 in remodeling nuclear architecture we
would need to visualize HSV-1 genome localization in WT and
p1302/2 nuclei by in situ hybridization or some other means.
Thus, at present we suggest three possible models by which
the pocket protein p130 plays a critical role in HSV-1 replica-
tion: (i) regulation of E2F transcription activities in order to
favor viral gene expression, (ii) inhibition of CDK activities in
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order to create a cell state favoring viral DNA replication,
and/or (iii) remodeling nuclear architecture in order to aid in
localization of viral genomes to ND10. While further studies
are necessary to obtain direct evidence that p130 interacts with
HSV-1 in one or more of these proposed ways, it is clear that
the presence of p130 in the cell is critical to timely and efficient
HSV-1 replication. Dissection of its role in viral growth will
direct us to a deeper understanding of virus host interactions.
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